Fundraising FoxFinchley Healthcare Ventures
Corporate VCMontreal · Seed–Series A · 15 people tracked
Find your way into Finchley Healthcare Ventures
Sign up to see every warm intro you have to Finchley Healthcare Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Finchley Healthcare Ventures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
The firm backs companies developing innovative, transformative prescription medicines aimed at addressing diseases not adequately served by current therapies. It is interested in a broad range of modalities, from small molecules and antibodies to breakthrough technologies such as nanotechnologies. Investment targets span companies approaching their first clinical trial through to those further along in development, with the goal of demonstrating proof of concept in humans. Beyond capital, the firm offers access to a network of professionals in medicine, pharmaceutical R&D, manufacturing, and commercialization to support product optimization and development. It also invests in life sciences venture funds and operates without geographic restriction.
Source: firm website, verified Sep 26, 2026.
Team · 15 people
from the firm's website & curated & public directories
What they invest in
from 6 of 6 portfolio companiesBiotech ×6Healthtech ×4Deep Tech ×3AI & Machine Learning ×2Medical Devices ×2
HQs:United States×4
Investments · 6 tracked
founders shown can be your intro path
AbbVie is a biopharmaceutical company that discovers and delivers medicines for immune-mediated diseases and other therapeutic areas globally.
BiotechHealthtechMedical DevicesSan Diego, US
Adrian Bot(Executive Officer)Laura Shawver(Executive Officer, Director)inRamin Farzaneh-Far(Executive Officer)inJustin Thacker(Executive Officer)Karen Smith(Director)Fabio Pucci(Director)
Co-investorsPfizer Venture InvestmentsRA CapitalSofinnova VenturesVida VenturesAlexandriaForbion
Cartography develops antibody-based cancer therapies using single-cell sequencing and computational biology to identify precise cellular targets.
AI & Machine LearningBiotechDeep TechMedical DevicesSouth San Francisco, US
Max Mumbach(Founding Scientist, Target Discovery)inJeffrey Verboon(Founding Scientist, Computational Biology)inAnsu Satpathy(Founder)Kevin Parker, PhD(Chief Executive Officer, Board Director; co-founder)Ansuman Satpathy, MD, PhD(Co-founder; Board Director)Howard Chang(Founder)in
Co-investors8VCAndreessen HorowitzArtis VenturesCatalio Capital Management, LPGaingelsGlobal BioAccess Fund+9 more
__Twitter.png)
Coultreon is a drug discovery and development company that advances small and large molecule therapeutic programmes across various disease areas, combining disease biology expertise with technology platforms.
AI & Machine LearningBiotech
Pierre Raboisson(Chief Executive Officer Chief Scientific Officer Co-founder)inMarie De Vulder(Chief Legal Officer Co-founder)inGuy Peeters(Chief Financial Officer Co-founder)inJohn-Paul Gallivan(Head of Development Co-founder)inFabrice Kolb(Head of Immunology Co-founder)inPieter Peeters(Operating & Technology Officer Co-founder)in
Co-investorsLongwood FundLuma GroupSofinnova VenturesBAM ElevateForbionNovo Holdings+2 more
Quanta is a biotech company developing orally bioavailable, CNS-penetrant small-molecule KRAS inhibitors targeting RAS-driven cancers such as pancreatic, colorectal, lung, and endometrial cancers.
BiotechDeep TechHealthtechSouth San Francisco, US
Cameron Pitt(Executive Officer, Director)inDerek Metzger(Executive Officer)
BoardMaha Katabi(Director)inPerry Nisen(Executive Officer, Director)inMaria Fardis(Director)inRajul Jain(Director)in
Co-investorsLongitude CapitalSofinnova VenturesVida VenturesBiotechnology Value FundFrazier Life Sciences
Reverb Therapeutics develops immunotherapies built on its Amplify•R platform, which modulates the body's natural immune system using targeted molecules such as IL-15-directed compounds.
BiotechHealthtech
Co-investorsAmplitude Venture CapitalInBC Investment Corp.Thin Air LabsKdT Ventures
TRIANA Biomedicines is a venture-backed biopharmaceutical company developing small-molecule "molecular glue" therapeutics that induce protein:protein interactions to degrade or alter disease-causing target proteins, with an initial focus on targeted protein degradation for cancer.
BiotechDeep TechHealthtechLexington, US
Patrick Trojer(President & Chief Executive Officer)in
Co-investorsAscenta CapitalAtlas VentureLightspeed Venture PartnersRA CapitalBessemer Venture PartnersPfizer Ventures+3 more
Portfolio news
latest coverage across their companiesCartography Biosciences · finsmes.com · May 7, 2026
Coultreon · coultreon.com · Apr 28, 2026
Frequently asked questions
- How many investments has Finchley Healthcare Ventures made?
- Finchley Healthcare Ventures has 6 tracked investments, including 1 dated in the last 24 months.
- What stage does Finchley Healthcare Ventures invest at?
- Finchley Healthcare Ventures invests at the Seed, Series A stages.
- What sectors does Finchley Healthcare Ventures focus on?
- Finchley Healthcare Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Finchley Healthcare Ventures located?
- Finchley Healthcare Ventures is headquartered in Montreal, CA.
- Who does Finchley Healthcare Ventures co-invest with?
- Finchley Healthcare Ventures most often shares deals with Pfizer Venture Investments, Sofinnova Ventures, RA Capital, among 21 tracked co-investors.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.